Incidental Mutation 'R1371:Acvr2a'
ID 157301
Institutional Source Beutler Lab
Gene Symbol Acvr2a
Ensembl Gene ENSMUSG00000052155
Gene Name activin receptor IIA
Synonyms Acvr2, ActRIIa, tActRII
MMRRC Submission 039435-MU
Accession Numbers
Essential gene? Non essential (E-score: 0.000) question?
Stock # R1371 (G1)
Quality Score 225
Status Validated
Chromosome 2
Chromosomal Location 48704121-48793276 bp(+) (GRCm39)
Type of Mutation missense
DNA Base Change (assembly) C to T at 48789628 bp (GRCm39)
Zygosity Heterozygous
Amino Acid Change Threonine to Methionine at position 457 (T457M)
Ref Sequence ENSEMBL: ENSMUSP00000067305 (fasta)
Gene Model predicted gene model for transcript(s): [ENSMUST00000028098] [ENSMUST00000063886]
AlphaFold P27038
PDB Structure CRYSTAL STRUCTURE OF THE EXTRACELLULAR DOMAIN OF THE TYPE II ACTIVIN RECEPTOR [X-RAY DIFFRACTION]
Crystal Structure of the BMP7/ActRII Extracellular Domain Complex [X-RAY DIFFRACTION]
Predicted Effect probably benign
Transcript: ENSMUST00000028098
SMART Domains Protein: ENSMUSP00000028098
Gene: ENSMUSG00000026761

DomainStartEndE-ValueType
AAA 57 199 2.75e-5 SMART
Pfam:ORC4_C 225 413 1.3e-51 PFAM
Predicted Effect probably damaging
Transcript: ENSMUST00000063886
AA Change: T457M

PolyPhen 2 Score 1.000 (Sensitivity: 0.00; Specificity: 1.00)
SMART Domains Protein: ENSMUSP00000067305
Gene: ENSMUSG00000052155
AA Change: T457M

DomainStartEndE-ValueType
signal peptide 1 19 N/A INTRINSIC
Pfam:Activin_recp 28 118 5e-10 PFAM
transmembrane domain 139 161 N/A INTRINSIC
Pfam:Pkinase_Tyr 192 479 1.2e-31 PFAM
Pfam:Pkinase 196 481 7.6e-34 PFAM
low complexity region 486 502 N/A INTRINSIC
Predicted Effect noncoding transcript
Transcript: ENSMUST00000156681
Meta Mutation Damage Score 0.6467 question?
Coding Region Coverage
  • 1x: 98.8%
  • 3x: 97.7%
  • 10x: 94.7%
  • 20x: 89.0%
Validation Efficiency 100% (55/55)
MGI Phenotype FUNCTION: [Summary is not available for the mouse gene. This summary is for the human ortholog.] This gene encodes a receptor that mediates the functions of activins, which are members of the transforming growth factor-beta (TGF-beta) superfamily involved in diverse biological processes. The encoded protein is a transmembrane serine-threonine kinase receptor which mediates signaling by forming heterodimeric complexes with various combinations of type I and type II receptors and ligands in a cell-specific manner. The encoded type II receptor is primarily involved in ligand-binding and includes an extracellular ligand-binding domain, a transmembrane domain and a cytoplasmic serine-threonine kinase domain. This gene may be associated with susceptibility to preeclampsia, a pregnancy-related disease which can result in maternal and fetal morbidity and mortality. Alternative splicing results in multiple transcript variants of this gene. [provided by RefSeq, Jun 2013]
PHENOTYPE: While most mice homozygous for targeted mutations that inactivate this gene appear normal, a few display skeletal and facial abnormalities. As adults, follicle-stimulating hormone is suppressed, affecting reproduction. [provided by MGI curators]
Allele List at MGI
Other mutations in this stock
Total: 49 list
GeneRefVarChr/LocMutationPredicted EffectZygosity
Abca8b T A 11: 109,844,379 (GRCm39) D884V probably damaging Het
Akr1b10 C T 6: 34,369,394 (GRCm39) T208I probably benign Het
Aldh16a1 G T 7: 44,796,674 (GRCm39) T275K possibly damaging Het
Alkbh2 C T 5: 114,262,287 (GRCm39) E148K probably damaging Het
Asgr1 T G 11: 69,946,923 (GRCm39) C56W probably benign Het
Atp11b T C 3: 35,860,918 (GRCm39) I335T probably damaging Het
BC061237 A G 14: 44,741,762 (GRCm39) probably benign Het
Bdh1 G T 16: 31,275,720 (GRCm39) K280N probably benign Het
Bmp1 C T 14: 70,729,906 (GRCm39) C466Y probably damaging Het
Ccdc181 A G 1: 164,108,172 (GRCm39) E285G probably benign Het
Ces1f C T 8: 94,006,277 (GRCm39) G18R probably damaging Het
Cfap43 T A 19: 47,824,045 (GRCm39) I109L possibly damaging Het
Cma2 T C 14: 56,210,283 (GRCm39) L56S probably damaging Het
Edc4 A G 8: 106,617,382 (GRCm39) probably benign Het
F3 T C 3: 121,526,159 (GRCm39) C241R probably damaging Het
Fhdc1 T A 3: 84,352,310 (GRCm39) S972C probably damaging Het
Heatr1 T G 13: 12,432,513 (GRCm39) I1086R possibly damaging Het
Hsh2d A T 8: 72,950,738 (GRCm39) probably benign Het
Ice1 T C 13: 70,744,340 (GRCm39) Y2081C probably damaging Het
Il1rl1 A G 1: 40,481,873 (GRCm39) N194D probably damaging Het
Ip6k1 G A 9: 107,923,022 (GRCm39) V385M probably damaging Het
Lig1 G A 7: 13,022,611 (GRCm39) R147Q probably damaging Het
Lrp1b C T 2: 40,537,165 (GRCm39) V41I probably damaging Het
Macroh2a2 A T 10: 61,585,112 (GRCm39) D177E possibly damaging Het
Mst1r T A 9: 107,794,424 (GRCm39) V1201E probably damaging Het
Myof T C 19: 37,892,116 (GRCm39) probably benign Het
Nbas G T 12: 13,532,379 (GRCm39) probably benign Het
Ndst1 A G 18: 60,840,719 (GRCm39) I321T possibly damaging Het
Nek10 G A 14: 14,850,983 (GRCm38) G343R probably damaging Het
Or2a7 A T 6: 43,151,234 (GRCm39) T105S probably benign Het
Or2y1 T A 11: 49,385,650 (GRCm39) C97S probably damaging Het
Or4d2b A T 11: 87,780,122 (GRCm39) I200N probably damaging Het
Pde4d T C 13: 109,253,595 (GRCm39) S141P probably benign Het
Pigm A T 1: 172,204,381 (GRCm39) Q39L probably damaging Het
Prl7a2 T A 13: 27,846,750 (GRCm39) I88F probably benign Het
Prss16 T A 13: 22,192,856 (GRCm39) probably benign Het
Psmc4 G A 7: 27,742,222 (GRCm39) probably benign Het
Ptger3 T A 3: 157,273,365 (GRCm39) C237* probably null Het
Recql G A 6: 142,318,601 (GRCm39) T214M probably damaging Het
Rfx7 T A 9: 72,526,857 (GRCm39) V1349D probably damaging Het
Ros1 A G 10: 51,964,041 (GRCm39) S1740P probably damaging Het
Rrm2b A T 15: 37,947,053 (GRCm39) S83T probably benign Het
Sall4 A G 2: 168,598,394 (GRCm39) Y149H probably benign Het
Smad1 A G 8: 80,076,207 (GRCm39) probably benign Het
Snrnp70 T C 7: 45,030,129 (GRCm39) probably benign Het
Spef2 C A 15: 9,725,194 (GRCm39) probably benign Het
Sptlc1 T C 13: 53,505,660 (GRCm39) T253A probably benign Het
Zbbx T C 3: 74,959,784 (GRCm39) Y595C possibly damaging Het
Zfp382 T C 7: 29,833,114 (GRCm39) V255A probably benign Het
Other mutations in Acvr2a
AlleleSourceChrCoordTypePredicted EffectPPH Score
IGL00756:Acvr2a APN 2 48,763,064 (GRCm39) splice site probably benign
IGL01551:Acvr2a APN 2 48,787,071 (GRCm39) missense probably damaging 1.00
IGL01913:Acvr2a APN 2 48,789,625 (GRCm39) missense probably damaging 1.00
IGL02100:Acvr2a APN 2 48,788,630 (GRCm39) splice site probably benign
IGL02210:Acvr2a APN 2 48,788,538 (GRCm39) missense probably damaging 0.99
R0864:Acvr2a UTSW 2 48,784,798 (GRCm39) splice site probably benign
R1676:Acvr2a UTSW 2 48,763,095 (GRCm39) missense probably benign 0.00
R2196:Acvr2a UTSW 2 48,760,324 (GRCm39) missense possibly damaging 0.94
R2876:Acvr2a UTSW 2 48,782,190 (GRCm39) missense probably damaging 1.00
R3721:Acvr2a UTSW 2 48,782,150 (GRCm39) missense probably damaging 1.00
R3763:Acvr2a UTSW 2 48,760,331 (GRCm39) missense possibly damaging 0.87
R4401:Acvr2a UTSW 2 48,789,714 (GRCm39) missense probably benign
R4724:Acvr2a UTSW 2 48,760,447 (GRCm39) missense probably damaging 1.00
R4921:Acvr2a UTSW 2 48,783,553 (GRCm39) missense possibly damaging 0.51
R5060:Acvr2a UTSW 2 48,780,311 (GRCm39) missense probably damaging 0.96
R5347:Acvr2a UTSW 2 48,782,166 (GRCm39) missense probably damaging 1.00
R5953:Acvr2a UTSW 2 48,780,416 (GRCm39) missense probably damaging 1.00
R6892:Acvr2a UTSW 2 48,787,087 (GRCm39) missense probably damaging 1.00
R7594:Acvr2a UTSW 2 48,784,749 (GRCm39) nonsense probably null
R7876:Acvr2a UTSW 2 48,760,439 (GRCm39) missense probably benign 0.01
R8123:Acvr2a UTSW 2 48,763,384 (GRCm39) missense probably damaging 0.99
R8296:Acvr2a UTSW 2 48,789,736 (GRCm39) missense possibly damaging 0.95
R8868:Acvr2a UTSW 2 48,763,469 (GRCm39) missense probably benign 0.00
R9034:Acvr2a UTSW 2 48,763,381 (GRCm39) missense probably damaging 1.00
R9181:Acvr2a UTSW 2 48,760,307 (GRCm39) missense probably damaging 0.99
Z1088:Acvr2a UTSW 2 48,760,385 (GRCm39) missense probably benign 0.01
Predicted Primers PCR Primer
(F):5'- TCACTCACATGCAGAGGCAGAAAG -3'
(R):5'- TTAGCAGCTCCAGTTCAGAGTCCC -3'

Sequencing Primer
(F):5'- GCTGGCTTGCATAATACACC -3'
(R):5'- AGTTCAGAGTCCCAGTCCTCAG -3'
Posted On 2014-02-18